Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Weight Gain and De Novo Metabolic Disorders after Liver Transplantation.

Lattanzi B, D'Ambrosio D, Tavano D, Pitoni D, Mennini G, Ginanni Corradini S, Rossi M, Merli M.

Nutrients. 2019 Dec 10;11(12). pii: E3015. doi: 10.3390/nu11123015.

2.

The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease.

Lattanzi B, Nardelli S, Pigliacelli A, Di Cola S, Farcomeni A, D'Ambrosio D, Gioia S, Ginanni Corradini S, Lucidi C, Mennini G, Rossi M, Merli M, Riggio O.

Dig Liver Dis. 2019 Nov;51(11):1508-1512. doi: 10.1016/j.dld.2019.09.004. Epub 2019 Oct 7.

PMID:
31601536
3.

The Effect of 12 Weeks of β-Hydroxy-β-Methyl-Butyrate Supplementation after Liver Transplantation: A Pilot Randomized Controlled Study.

Lattanzi B, Giusto M, Albanese C, Mennini G, D'Ambrosio D, Farcomeni A, Ginanni Corradini S, Rossi M, Merli M.

Nutrients. 2019 Sep 19;11(9). pii: E2259. doi: 10.3390/nu11092259.

4.

Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis.

Fernández J, Angeli P, Trebicka J, Merli M, Gustot T, Alessandria C, Aagaard NK, de Gottardi A, Welzel TM, Gerbes A, Soriano G, Vargas V, Albillos A, Salerno F, Durand F, Bañares R, Stauber R, Prado V, Arteaga M, Hernández-Tejero M, Aziz F, Morando F, Jansen C, Lattanzi B, Moreno C, Campion D, Gronbaek H, Garcia R, Sánchez C, García E, Amorós A, Pavesi M, Clària J, Moreau R, Arroyo V.

Clin Gastroenterol Hepatol. 2019 Aug 5. pii: S1542-3565(19)30844-4. doi: 10.1016/j.cgh.2019.07.055. [Epub ahead of print]

PMID:
31394283
5.

Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients.

Ferri F, Lai Q, Molinaro A, Poli E, Parlati L, Lattanzi B, Mennini G, Melandro F, Pugliese F, Maldarelli F, Corsi A, Riminucci M, Merli M, Rossi M, Ginanni Corradini S.

Can J Gastroenterol Hepatol. 2019 May 2;2019:5862985. doi: 10.1155/2019/5862985. eCollection 2019.

6.

Prevalence and impact of sarcopenia in non-cirrhotic portal hypertension.

Lattanzi B, Gioia S, Di Cola S, D'Ambrosio D, Nardelli S, Tavano D, Farcomeni A, Merli M, Riggio O.

Liver Int. 2019 Oct;39(10):1937-1942. doi: 10.1111/liv.14160. Epub 2019 Jun 26.

PMID:
31152475
7.

Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.

Nardelli S, Lattanzi B, Merli M, Farcomeni A, Gioia S, Ridola L, Riggio O.

Hepatology. 2019 Nov;70(5):1704-1713. doi: 10.1002/hep.30692. Epub 2019 Jun 28.

PMID:
31038758
8.

Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.

Praktiknjo M, Clees C, Pigliacelli A, Fischer S, Jansen C, Lehmann J, Pohlmann A, Lattanzi B, Krabbe VK, Strassburg CP, Arroyo V, Merli M, Meyer C, Trebicka J.

Clin Transl Gastroenterol. 2019 Apr;10(4):e00025. doi: 10.14309/ctg.0000000000000025.

9.

Sarcopenic obesity in fatty liver.

Merli M, Lattanzi B, Aprile F.

Curr Opin Clin Nutr Metab Care. 2019 May;22(3):185-190. doi: 10.1097/MCO.0000000000000558.

PMID:
30893090
10.

Hepatic Encephalopathy and Sarcopenia: Two Faces of the Same Metabolic Alteration.

Lattanzi B, D'Ambrosio D, Merli M.

J Clin Exp Hepatol. 2019 Jan-Feb;9(1):125-130. doi: 10.1016/j.jceh.2018.04.007. Epub 2018 May 5. Review.

11.

The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS.

Gioia S, Merli M, Nardelli S, Lattanzi B, Pitocchi F, Ridola L, Riggio O.

Liver Int. 2019 May;39(5):871-877. doi: 10.1111/liv.14050. Epub 2019 Feb 6.

PMID:
30667572
12.

Ischemic Damage Represents the Main Risk Factor for Biliary Stricture After Liver Transplantation: A Follow-Up Study in a Danish Population.

Lattanzi B, Ott P, Rasmussen A, Kudsk KR, Merli M, Villadsen GE.

In Vivo. 2018 Nov-Dec;32(6):1623-1628. doi: 10.21873/invivo.11423.

13.

Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients.

Lattanzi B, Baroncelli S, De Santis A, Galluzzo CM, Mennini G, Michelini Z, Lupo M, Ginanni Corradini S, Rossi M, Palmisano L, Merli M.

Aliment Pharmacol Ther. 2018 Nov;48(10):1146-1155. doi: 10.1111/apt.14994. Epub 2018 Oct 8.

PMID:
30294870
14.

Donor-to-recipient gender match in liver transplantation: A systematic review and meta-analysis.

Lai Q, Giovanardi F, Melandro F, Larghi Laureiro Z, Merli M, Lattanzi B, Hassan R, Rossi M, Mennini G.

World J Gastroenterol. 2018 May 28;24(20):2203-2210. doi: 10.3748/wjg.v24.i20.2203. Review.

15.

May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease?

Lucidi C, Lattanzi B, Riggio O, Merli M.

J Hepatol. 2018 Jun;68(6):1324-1325. doi: 10.1016/j.jhep.2018.02.035. Epub 2018 Apr 5. No abstract available.

PMID:
29627223
16.

The multidisciplinary support in preventing alcohol relapse after liver transplantation: A single-center experience.

Attilia ML, Lattanzi B, Ledda R, Galli AM, Farcomeni A, Rotondo C, Di Gregorio V, Mennini G, Poli E, Attilia F, Ginanni Corradini S, Rossi M, Merli M.

Clin Transplant. 2018 May;32(5):e13243. doi: 10.1111/ctr.13243. Epub 2018 Apr 11.

PMID:
29573476
17.

A low muscle mass increases mortality in compensated cirrhotic patients with sepsis.

Lucidi C, Lattanzi B, Di Gregorio V, Incicco S, D'Ambrosio D, Venditti M, Riggio O, Merli M.

Liver Int. 2018 May;38(5):851-857. doi: 10.1111/liv.13691. Epub 2018 Feb 10.

PMID:
29323441
18.

MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective.

Cavaggioni G, Poli E, Ferri F, Parlati L, Monaco V, Melcore C, Lattanzi B, Merli M, Mennini G, Melandro F, Rossi M, Ginanni Corradini S.

Metab Brain Dis. 2017 Jun;32(3):923-933. doi: 10.1007/s11011-017-9987-2. Epub 2017 Apr 11.

PMID:
28397153
19.

Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial.

Ravelli A, Davì S, Bracciolini G, Pistorio A, Consolaro A, van Dijkhuizen EHP, Lattanzi B, Filocamo G, Verazza S, Gerloni V, Gattinara M, Pontikaki I, Insalaco A, De Benedetti F, Civino A, Presta G, Breda L, Marzetti V, Pastore S, Magni-Manzoni S, Maggio MC, Garofalo F, Rigante D, Gattorno M, Malattia C, Picco P, Viola S, Lanni S, Ruperto N, Martini A; Italian Pediatric Rheumatology Study Group.

Lancet. 2017 Mar 4;389(10072):909-916. doi: 10.1016/S0140-6736(17)30065-X. Epub 2017 Feb 3.

PMID:
28162781
20.

Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.

Nardelli S, Lattanzi B, Torrisi S, Greco F, Farcomeni A, Gioia S, Merli M, Riggio O.

Clin Gastroenterol Hepatol. 2017 Jun;15(6):934-936. doi: 10.1016/j.cgh.2016.10.028. Epub 2016 Nov 2.

PMID:
27816756
21.

Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.

Lucidi C, Ginanni Corradini S, Abraldes JG, Merli M, Tandon P, Ferri F, Parlati L, Lattanzi B, Poli E, Di Gregorio V, Farcomeni A, Riggio O.

Liver Transpl. 2016 Oct;22(10):1333-42. doi: 10.1002/lt.24517.

22.

Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome.

Omenetti A, Carta S, Caorsi R, Finetti M, Marotto D, Lattanzi B, Jorini M, Delfino L, Penco F, Picco P, Buoncompagni A, Martini A, Rubartelli A, Gattorno M.

Rheumatology (Oxford). 2016 Jul;55(7):1325-35. doi: 10.1093/rheumatology/kew031. Epub 2016 Mar 17.

PMID:
26989109
23.

An empirical broad spectrum antibiotic therapy in health-care-associated infections improves survival in patients with cirrhosis: A randomized trial.

Merli M, Lucidi C, Di Gregorio V, Lattanzi B, Giannelli V, Giusto M, Farcomeni A, Ceccarelli G, Falcone M, Riggio O, Venditti M.

Hepatology. 2016 May;63(5):1632-9. doi: 10.1002/hep.28332. Epub 2016 Jan 5.

PMID:
26529126
24.

The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.

Merli M, Lucidi C, Di Gregorio V, Falcone M, Giannelli V, Lattanzi B, Giusto M, Ceccarelli G, Farcomeni A, Riggio O, Venditti M.

PLoS One. 2015 May 21;10(5):e0127448. doi: 10.1371/journal.pone.0127448. eCollection 2015.

25.

Albumin infusion in cirrhotic patients with infections other than spontaneous bacterial peritonitis: End of the story?

Merli M, Lucidi C, Lattanzi B, Riggio O.

J Hepatol. 2015 Sep;63(3):767-8. doi: 10.1016/j.jhep.2015.04.028. Epub 2015 May 16. No abstract available.

26.

Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.

Minoia F, Davì S, Horne A, Bovis F, Demirkaya E, Akikusa J, Ayaz NA, Al-Mayouf SM, Barone P, Bica B, Bolt I, Breda L, De Cunto C, Enciso S, Gallizzi R, Griffin T, Hennon T, Horneff G, Jeng M, Kapovic AM, Lipton JM, Magni Manzoni S, Rumba-Rozenfelde I, Magalhaes CS, Sewairi WM, Stine KC, Vougiouka O, Weaver LK, Davidsone Z, De Inocencio J, Ioseliani M, Lattanzi B, Tezer H, Buoncompagni A, Picco P, Ruperto N, Martini A, Cron RQ, Ravelli A; Pediatric Rheumatology International Trials Organization; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society.

J Rheumatol. 2015 Jun;42(6):994-1001. doi: 10.3899/jrheum.141261. Epub 2015 Apr 15.

PMID:
25877504
27.

Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry.

Giusto M, Lattanzi B, Albanese C, Galtieri A, Farcomeni A, Giannelli V, Lucidi C, Di Martino M, Catalano C, Merli M.

Eur J Gastroenterol Hepatol. 2015 Mar;27(3):328-34. doi: 10.1097/MEG.0000000000000274.

PMID:
25569567
28.

Changes in nutritional status after liver transplantation.

Giusto M, Lattanzi B, Di Gregorio V, Giannelli V, Lucidi C, Merli M.

World J Gastroenterol. 2014 Aug 21;20(31):10682-90. doi: 10.3748/wjg.v20.i31.10682. Review.

29.

Female sex and oligoarthritis category are not risk factors for uveitis in Italian children with juvenile idiopathic arthritis.

Calandra S, Gallo MC, Consolaro A, Pistorio A, Lattanzi B, Bovis F, Muratore V, De Marco R, Martini A, Ravelli A.

J Rheumatol. 2014 Jul;41(7):1416-25. doi: 10.3899/jrheum.131494. Epub 2014 Jun 15.

PMID:
24931957
30.

Beta-blockers in liver cirrhosis.

Giannelli V, Lattanzi B, Thalheimer U, Merli M.

Ann Gastroenterol. 2014;27(1):20-26. Review.

31.

Conversion from twice-daily to once-daily Tacrolimus administration in liver transplant patient: results of long term follow-up.

Giannelli V, Rossi M, Giusto M, Lucidi C, Lattanzi B, Ruffa A, Ginanni Corradini S, Mennini G, Melandro F, Lai Q, Berloco P, Merli M.

Eur Rev Med Pharmacol Sci. 2013 Oct;17(20):2718-20.

32.

Graft macrosteatosis and time of T-tube removal as risk factors for biliary strictures after liver transplantation.

Lattanzi B, Lai Q, Guglielmo N, Giannelli V, Merli M, Giusto M, Melandro F, Ginanni Corradini S, Mennini G, Berloco PB, Rossi M.

Clin Transplant. 2013 May-Jun;27(3):E332-8. doi: 10.1111/ctr.12124. Epub 2013 May 6.

PMID:
23647461
33.

Increased risk of cognitive impairment in cirrhotic patients with bacterial infections.

Merli M, Lucidi C, Pentassuglio I, Giannelli V, Giusto M, Di Gregorio V, Pasquale C, Nardelli S, Lattanzi B, Venditti M, Riggio O.

J Hepatol. 2013 Aug;59(2):243-50. doi: 10.1016/j.jhep.2013.03.012. Epub 2013 Mar 21.

PMID:
23523580
34.

Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study.

Merli M, Giusto M, Lucidi C, Giannelli V, Pentassuglio I, Di Gregorio V, Lattanzi B, Riggio O.

Metab Brain Dis. 2013 Jun;28(2):281-4. doi: 10.1007/s11011-012-9365-z. Epub 2012 Dec 7.

PMID:
23224378
36.

Glucocorticoids in paediatric rheumatology.

Ravelli A, Lattanzi B, Consolaro A, Martini A.

Clin Exp Rheumatol. 2011 Sep-Oct;29(5 Suppl 68):S148-52. Epub 2011 Oct 22. Review.

PMID:
22018202
37.

Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritis.

Consolaro A, Ruperto N, Pistorio A, Lattanzi B, Solari N, Galasso R, Pederzoli S, Varnier GC, Dolezalova P, Alessio M, Burgos-Vargas R, Vesely R, Martini A, Ravelli A; Paediatric Rheumatology International Trials Organisation.

Arthritis Care Res (Hoboken). 2011 Sep;63(9):1262-70. doi: 10.1002/acr.20509.

38.

Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis.

Lanni S, Bertamino M, Consolaro A, Pistorio A, Magni-Manzoni S, Galasso R, Lattanzi B, Calvo-Aranda E, Martini A, Ravelli A.

Rheumatology (Oxford). 2011 Sep;50(9):1627-34. doi: 10.1093/rheumatology/ker165. Epub 2011 May 11.

PMID:
21561981
39.

A new approach to clinical care of juvenile idiopathic arthritis: the Juvenile Arthritis Multidimensional Assessment Report.

Filocamo G, Consolaro A, Schiappapietra B, Dalprà S, Lattanzi B, Magni-Manzoni S, Ruperto N, Pistorio A, Pederzoli S, Civino A, Guseinova D, Masala E, Viola S, Martini A, Ravelli A.

J Rheumatol. 2011 May;38(5):938-53. doi: 10.3899/jrheum.100930. Epub 2011 Mar 1.

PMID:
21362761
40.

Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis.

Ravelli A, Varnier GC, Oliveira S, Castell E, Arguedas O, Magnani A, Pistorio A, Ruperto N, Magni-Manzoni S, Galasso R, Lattanzi B, Dalprà S, Battagliese A, Verazza S, Allegra M, Martini A.

Arthritis Rheum. 2011 Jan;63(1):267-75. doi: 10.1002/art.30076.

41.

Evaluation of 21-numbered circle and 10-centimeter horizontal line visual analog scales for physician and parent subjective ratings in juvenile idiopathic arthritis.

Filocamo G, Davì S, Pistorio A, Bertamino M, Ruperto N, Lattanzi B, Consolaro A, Magni-Manzoni S, Galasso R, Varnier GC, Martini A, Ravelli A.

J Rheumatol. 2010 Jul;37(7):1534-41. doi: 10.3899/jrheum.091474. Epub 2010 Jun 15.

PMID:
20551105
42.

A new short and simple health-related quality of life measurement for paediatric rheumatic diseases: initial validation in juvenile idiopathic arthritis.

Filocamo G, Schiappapietra B, Bertamino M, Pistorio A, Ruperto N, Magni-Manzoni S, Lanni S, Saad-Magalhaes C, Galasso R, Lattanzi B, Muratore V, Tani D, Martini A, Ravelli A.

Rheumatology (Oxford). 2010 Jul;49(7):1272-80. doi: 10.1093/rheumatology/keq065. Epub 2010 Mar 24.

PMID:
20338888
43.

Home monitoring anticoagulation therapy in infants.

de Benedictis FM, Lattanzi B, Colaneri M.

Arch Dis Child. 2008 Aug;93(8):714. No abstract available.

PMID:
18644938
44.

Physicians' and parents' ratings of inactive disease are frequently discordant in juvenile idiopathic arthritis.

Consolaro A, Vitale R, Pistorio A, Lattanzi B, Ruperto N, Malattia C, Filocamo G, Viola S, Martini A, Ravelli A.

J Rheumatol. 2007 Aug;34(8):1773-6. Epub 2007 Jul 1.

PMID:
17611978
45.

Evidence for chestnut pollinosis in Paris.

Laurent J, Lafay M, Lattanzi B, Le Gall C, Sauvaget J.

Clin Exp Allergy. 1993 Jan;23(1):39-43.

PMID:
8439819
46.

[Allergy to tree pollens in Paris and the Paris area].

Choquet PH, Lattanzi B, Vai F, Domini D, Sutra JP, Sauvaget J.

Presse Med. 1986 May 31;15(22):1046-7. French. No abstract available.

PMID:
2942876

Supplemental Content

Loading ...
Support Center